Proteopedia:Topic Pages: Difference between revisions
No edit summary |
m Protected "Proteopedia:Topic Pages" [edit=sysop:move=sysop] |
||
| (27 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
[[Topic | [[Proteopedia:Topic_Pages|Topic Pages]] are pages about proteins or molecules or families of proteins or molecules, or [[About Macromolecular Structure|structural biology concepts or terms]]. Topic pages are not titled with a [[PDB]] code. In contrast to topic pages, [[Proteopedia]] contains a page for each entry in the PDB, created automatically, and titled with the PDB code. These pages generally describe a particular solved structure. A topic page like [[hemoglobin]], however, will address the protein in general, and refer to several solved structures such as [[1gzx]] and [[2hbs]]. And so, topic pages can be thought of as higher up in the heirarchy of page organization in Proteopedia than are PDB-code-titled pages. The list of structures related to a given topic page are listed on a related [[Proteopedia:3D structures pages|3D structures page]]. These pages are created manually, never automatically. | ||
You might also be interested in Proteopedia's [[Table of Contents]]. | You might also be interested in Proteopedia's [[Table of Contents]]. | ||
| Line 11: | Line 11: | ||
<big><big>'''See also: [[About Macromolecular Structure]]'''</big>, a list of pages not listed below.</big> | <big><big>'''See also: [[About Macromolecular Structure]]'''</big>, a list of pages not listed below.</big> | ||
<!-- Start of topic pages. Please DON'T REMOVE --> | <!-- Start of topic pages. Please DON'T REMOVE --> | ||
===A | ===A=== | ||
*[[AChE inhibitors and substrates]], [[AChE inhibitors and substrates (Part II) | PartII]], [[AChE inhibitors and substrates (Part III) | PartIII]] | *[[AChE inhibitors and substrates]], [[AChE inhibitors and substrates (Part II) | PartII]], [[AChE inhibitors and substrates (Part III) | PartIII]] | ||
**[[AChE bivalent inhibitors|AChE bivalent inhibitors, Part I]], [[AChE bivalent inhibitors (Part II)|Part II]] | **[[AChE bivalent inhibitors|AChE bivalent inhibitors, Part I]], [[AChE bivalent inhibitors (Part II)|Part II]] | ||
| Line 19: | Line 19: | ||
<!-- *[[Antibodies]] --> | <!-- *[[Antibodies]] --> | ||
*[[A Physical Model of the β2-Adrenergic Receptor|β2-Adrenergic Receptor, A Physical Model of the]] | *[[A Physical Model of the β2-Adrenergic Receptor|β2-Adrenergic Receptor, A Physical Model of the]] | ||
*[[Alpha-1-antitrypsin | *[[Alpha-1-antitrypsin]] | ||
*[[Pore forming toxin, α- | *[[Pore forming toxin, α-hemolysin|α-hemolysin]] | ||
*[[Amino Acids]] with info about [[Selenocysteine]] and [[Pyrrolysine]] | *[[Amino Acids]] with info about [[Selenocysteine]] and [[Pyrrolysine]] | ||
*[[Annexin]] | *[[Annexin]] | ||
| Line 28: | Line 28: | ||
*[[Avian Influenza Neuraminidase, Tamiflu and Relenza]] | *[[Avian Influenza Neuraminidase, Tamiflu and Relenza]] | ||
*[[Avidin]] | *[[Avidin]] | ||
===B - C=== | |||
*[[Bacterial Intein-Like Domains (BILs)]] | *[[Bacterial Intein-Like Domains (BILs)]] | ||
*[[Believe It or Not!]] | *[[Believe It or Not!]] | ||
| Line 33: | Line 35: | ||
*[[C-di-GMP]] | *[[C-di-GMP]] | ||
*[[C-di-GMP signaling]] | *[[C-di-GMP signaling]] | ||
*[[ | *[[Chitinase]] | ||
*[[Cyt2Ba]] | *[[Cyt2Ba]] | ||
===D - | ===D - F=== | ||
*[[DHFR]] | *[[DHFR]] | ||
*[[Dihydrofolate reductase]] | *[[Dihydrofolate reductase]] | ||
| Line 52: | Line 54: | ||
*[[Extremophiles]] | *[[Extremophiles]] | ||
<!-- *[[Fibrin]] --> | <!-- *[[Fibrin]] --> | ||
*[[Ferredoxin | *[[Ferredoxin]] | ||
*[[Filamin]] | *[[Filamin]] | ||
*[[Flavodoxin]] | *[[Flavodoxin]] | ||
*[[Forms of DNA]] | |||
===G - L=== | |||
*[[Gelsolin]] | *[[Gelsolin]] | ||
*[[Glycine]] | *[[Glycine]] | ||
*[[Glutamate receptor (GluA2)|The Glutamate Receptor]] | *[[Glutamate receptor (GluA2)|The Glutamate Receptor]] | ||
*[[Gramicidin Channel in Lipid Bilayer | *[[Gramicidin Channel in Lipid Bilayer]] | ||
*[[Green Fluorescent Protein]] | *[[Green Fluorescent Protein]] | ||
*[[Heme]] | *[[Heme]] | ||
*[[Hemoglobin]] | *[[Hemoglobin]] | ||
*[[Pore forming toxin, α- | *[[Pore forming toxin, α-hemolysin|hemolysin]] | ||
*[[High school teachers' resources]] | *[[High school teachers' resources]] | ||
*[[Highest impact structures]] | *[[Highest impact structures]] | ||
*[[Hint auto-proteolytic protein-processing domains]] | *[[Hint auto-proteolytic protein-processing domains]] | ||
*[[Flaps Morph for HIV Protease|HIV Protease: Flaps Morph]] | |||
*[[Molecular Playground/HIV Protease Inhibitor|HIV Protease Inhibitor]] | |||
*[[Immunodeficiency virus protease]] | |||
*[[Intrinsically Disordered Protein]] | *[[Intrinsically Disordered Protein]] | ||
*[[Ion channels]] | *[[Ion channels]] | ||
*[[Lac repressor]] | *[[Lac repressor]] | ||
*[[Lactose Permease]] | *[[Lactose Permease]] | ||
*[[User:Wayne_Decatur/Haloarcula Large Ribosomal Subunit|Large Ribosomal Subunit]] [[ | *[[User:Wayne_Decatur/Haloarcula Large Ribosomal Subunit|Large Ribosomal Subunit]] | ||
*[[Lipase]] | |||
*[[Lipase lid morph]] | |||
*[[Luciferase]] | *[[Luciferase]] | ||
===M - | ===M - N=== | ||
*[[Major Histocompatibility Complex Class I]]: Crucial to your defenses against viruses, and one of the [[Highest impact structures | Highest Impact Structures of All Time]] | *[[Major Histocompatibility Complex Class I]]: Crucial to your defenses against viruses, and one of the [[Highest impact structures | Highest Impact Structures of All Time]] | ||
*[[Matrix metalloproteinases]] | *[[Matrix metalloproteinases]] | ||
*[[Mechanosensitive channels: opening and closing]] (includes morphs) | *[[Mechanosensitive channels: opening and closing]] (includes morphs) | ||
*[[Membrane proteins]] | *[[Membrane proteins]] | ||
*[[Metal-Ligand Polyhedra]] | *[[Metal-Ligand Polyhedra]] | ||
*[[Metalloproteases]] | *[[Metalloproteases]] | ||
*[[Morphs]] of conformational changes of macromolecules | *[[Morphs]] of conformational changes of macromolecules | ||
*[[NADH quinone oxidoreductase (NQO1) with inhibitor dicoumarol|NADH quinone oxidoreductase (NQO1)]] | *[[NADH quinone oxidoreductase (NQO1) with inhibitor dicoumarol|NADH quinone oxidoreductase (NQO1)]] | ||
*[[Nitrotyrosine]], a post-translational modification occurring in inflammation that often inactivates enzymes. | *[[Nitrotyrosine]], a post-translational modification occurring in inflammation that often inactivates enzymes. | ||
*[[Nobel Prizes for 3D Molecular Structure]] including the 2009 Chemistry Prize for the [[Ribosome]] | *[[Nobel Prizes for 3D Molecular Structure]] including the 2009 Chemistry Prize for the [[Ribosome]] | ||
*[[Non-Standard Residues]], see also [[Standard Residues]] | *[[Non-Standard Residues]], see also [[Standard Residues]] | ||
*[[Nucleoporin]] | *[[Nucleoporin]] | ||
*[[Nucleosomes]] | *[[Nucleosomes]] | ||
===O - P=== | |||
*[[OhrR]] | *[[OhrR]] | ||
*[[P53]] | *[[P53]] | ||
| Line 93: | Line 105: | ||
*[[Phosphoglucoisomerase]] | *[[Phosphoglucoisomerase]] | ||
*[[Photosystem II]] | *[[Photosystem II]] | ||
*[[Plant Viral Protein p19 Suppression of RNA Silencing | *[[Plant Viral Protein p19 Suppression of RNA Silencing]] | ||
*[[Porin]] | *[[Porin]] | ||
*[[Prion protein]] | *[[Prion protein]] | ||
| Line 100: | Line 112: | ||
*[[Pyruvate phosphate dikinase]] | *[[Pyruvate phosphate dikinase]] | ||
===R | ===R=== | ||
*[[Recombinase A]] | *[[Recombinase A]] | ||
*[[Recoverin, a calcium-activated myristoyl switch]] | *[[Recoverin, a calcium-activated myristoyl switch]] | ||
| Line 106: | Line 118: | ||
*[[Resolvase]] | *[[Resolvase]] | ||
*[[Reverse transcriptase]] | *[[Reverse transcriptase]] | ||
*[[Resolution]] | |||
*[[Ribosome]] | *[[Ribosome]] | ||
*[[RNA motifs]] | *[[RNA motifs]] | ||
*[[Rop protein]] | *[[Rop protein]] | ||
===S=== | |||
*[[SGAP]] | *[[SGAP]] | ||
*[[Scene authoring tools]] | *[[Scene authoring tools]] | ||
*[[SelB Recognition]] | *[[SelB|SelB Recognition]] | ||
*[[Selenocysteine]] | *[[Selenocysteine]] | ||
*[[Serine Protease]] | *[[Serine Protease]] | ||
| Line 119: | Line 134: | ||
*[[Site | Sites, Functional]] | *[[Site | Sites, Functional]] | ||
*[[Standard Residues]] (see also [[Non-Standard Residues]] | *[[Standard Residues]] (see also [[Non-Standard Residues]] | ||
*[[ | *[[Strictosidine Synthase]] | ||
*[[Highest impact structures|Structures saving the most lives]] | *[[Highest impact structures|Structures saving the most lives]] | ||
*[[Suppression of RNA Silencing by Viruses]] | *[[Suppression of RNA Silencing by Viruses]] | ||
===T - Z=== | |||
*[[TATA-Binding Protein]] | *[[TATA-Binding Protein]] | ||
*[[Teaching Strategies Using Proteopedia]] | *[[Teaching Strategies Using Proteopedia]] | ||
| Line 127: | Line 144: | ||
*[[TEM1-beta-Lactamase/beta-lactamase Inhibitor Protein (BLIP)]] | *[[TEM1-beta-Lactamase/beta-lactamase Inhibitor Protein (BLIP)]] | ||
*[[Tetrameric alcohol dehydrogenases]] | *[[Tetrameric alcohol dehydrogenases]] | ||
*[[Thermal motion of peptide]] | |||
*[[Herpes Simplex Virus Thymidine Kinase|Thymidine Kinase, Herpes Simplex Virus]] | *[[Herpes Simplex Virus Thymidine Kinase|Thymidine Kinase, Herpes Simplex Virus]] | ||
*[[Transcription Termination Factor Rho]] | *[[Transcription Termination Factor Rho]] | ||
*[[Treatment of Gaucher disease]] | *[[Treatment of Gaucher disease]] | ||
*[[Tropomyosin]] | *[[Tropomyosin]] | ||
*[[Tutorial:Ramachandran principle and phi psi angles]] | |||
*[[User:Eric Martz/Sandbox 8|Water]] with electrostatic potential surface / [[User:Gabriel Pons/Sandbox 1|El Agua]] | |||
*[[Villin]] | *[[Villin]] | ||
*[[Vinculin]] | *[[Vinculin]] | ||